MedPath
NMPA Approval

Mirtazapine Tablets

国药准字HJ20181173

July 29, 2022

H20181173

Drug Information

米氮平片

片剂

30mg

化学药品

July 29, 2022

July 28, 2027

Company Information

Applicant Company

Sandoz Gmbh

Biochemiestraße 10, 6250 Kundl, Austria

Manufacturing Company

Squibb Road, Cherag Ali Market Tongi Industrial Area, Gazipur-1711, Bangladesh

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米氮平片 - NMPA 批准文号 | MedPath